Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000228153 | SCV000287028 | benign | Primary ciliary dyskinesia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000253825 | SCV000307594 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000228153 | SCV000468168 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000515080 | SCV000610679 | likely benign | not provided | 2017-04-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002227098 | SCV002506087 | benign | Primary ciliary dyskinesia 7 | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000228153 | SCV002683675 | benign | Primary ciliary dyskinesia | 2017-04-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000515080 | SCV004169120 | likely benign | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |